Speaker Abstracts

References

• Buckley NA, McManus PR. Drug Safety 1998; 18(5)369–81
   PubMed Web of Science ®Google Scholar
• Schulz M, Schmoldt A. Pharmazie 2003; 58: 447–74
   PubMed Web of Science ®Google Scholar
• Frey, R, Kindler, J, Bur, A, Heiden, A, Laggner, A, Kasper, S. Eur Arch Psychiatry Clin Neurosci 2004;254, (Suppl.1)I/16.
   Google Scholar
• Henry JA, Alexander CA, Sener EK. BMJ 1995; 310: 221–4
   PubMed Web of Science ®Google Scholar
• Frey R, Schreinzer D, Stimpfl T, Vycudilik W, Berzlanovich A, Kasper S. Eur Neuropsychopharmacol 2000; 10(2)133–42
   PubMed Web of Science ®Google Scholar
• Drescher KD, Rosen CS, Burling TA, Foy DW. Causes of death among male veterans who received residential treatment for PTSD. J Trauma Stress 2003; 16(6)535–43
   PubMed Web of Science ®Google Scholar
• Bullman TA, Kang HK, Watanabe KK. Proportionate mortality among US Army Vietnam veterans who served in military region I. Am J Epidemiol 1990; 132(4)670–4
   PubMed Web of Science ®Google Scholar
• Angst J, et al. Recurrent brief depression: a new subtype of affective disorder. J Affect Dis 1990; 19: 87–98
   PubMed Web of Science ®Google Scholar
• Pezawas L, et al. Recurrent brief depression-past and future. Prog Neuro-Psychopharm Biolog Psych 2003; 27: 75–83
   PubMed Web of Science ®Google Scholar
• Carta, et al. Recurrent brief depression in celiac disease. J Psychosom Res 2003; 55: 573–4
   PubMed Web of Science ®Google Scholar
• Pezawas L, et al. 5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression. Nat Neurosci 2005; 8: 828–34
   PubMed Web of Science ®Google Scholar
• Pezawas L, et al. The Brain-Derived Neurotrophic Factor val66met Polymorphism and Variation in Human Cortical Morphology. J Neurosci 2004; 24: 10099–102
   PubMed Web of Science ®Google Scholar
• Egan MF, et al. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 2003; 112: 257–69
   PubMed Web of Science ®Google Scholar
• Hariri AR, et al. Serotonin transporter genetic variation and the response of the human amygdala. Science 2002; 297: 400–3
   PubMed Web of Science ®Google Scholar
• Hariri AR, et al. Brain-derived neurotrophic factor val66met polymorphism affects human memory-related hippocampal activity and predicts memory performance. J Neurosci 2003; 23: 6690–4
   PubMed Web of Science ®Google Scholar
• Lepola U, Wade A, Andersen HF. Do equivalent doses of escitalopram and citalopram have similar efficacy? A pooled analysis of two positive placebo-controlled studies in major depressive disorder. Int Clin Psychopharmacol 2004; 19: 149–55
   PubMed Web of Science ®Google Scholar
• Moore N, Verdoux H, Fantinoe B. Prospective, multicentre, randomized, double-blind study of the efficacy of escitalopram versus citalopram in outpatient treatment of major depressive disorder. Int Clin Psychopharmacol 2005; 20: 131–37
   PubMed Web of Science ®Google Scholar
• Kennedy, S, Andersen, EW. A pooled analysis of selective serotonin reuptake inhibitors and venlafaxine. Poster presented at the 158th Annual Meeting of the American Psychiatric Association, May21–26, 2005, Atlanta, Georgia.
   Google Scholar
• Behnke K, Søgaard J, Martin S, et al. Mirtazapine orally disintegrating tablet versus sertraline: a prospective onset of action study. J Clin Psychopharmacology 2003; 23: 358–64
   PubMed Web of Science ®Google Scholar
• Guelfi JD, Ansseau M, Timmerman L, Korsgaard S, Mirtazapine-Venlafaxine StudyGroup. Mirtazapine versus venlafaxine in hospitalized severely depressed patients with melancholic features. J Clin Psychopharmacol 2001; 21: 425
   PubMed Web of Science ®Google Scholar
• Montgomery SA, et al. J Affective Disord 2002; 69: 119–40
   PubMed Web of Science ®Google Scholar
• Montejo AL, Llorca G, Izquierdo JA, et al. Villademoreos. J Clin Psychiatry 2001; 62(suppl 3)10–21
   PubMed Web of Science ®Google Scholar
• Kennedy S, et al. Eur Neuropsychopharmacology 1996; 6: 177–81
   PubMed Web of Science ®Google Scholar
• Fava, et al. Sexual functioning and SSRIs. J Clin Psychiatry 2002; 63(suppl 5)13–6
   PubMedGoogle Scholar
• Lôo H, et al. Int Clin Psychopharmacol 2002; 17: 239–47
   PubMed Web of Science ®Google Scholar
• Field MJ, et al. Pregabalin may represent a novel class of anxiolytic agents with broad spectrum of activity. Br J Pharmacol 2001; 132(1)1–4
   PubMed Web of Science ®Google Scholar
• Pohl, RB, , et al. Efficacy of pregabalin in the treatment of generalized anxiety disorder. Double-blind, placebo-controlled comparison of bid versus tid dosing. J Clin Psychopharmacol 2005: in press.
   PubMed Web of Science ®Google Scholar
• Rickels, K, , et al. Pregabalin's persistent efficacy in the treatment of physical-somatic symptoms in outpatients with generalized anxiety disorder (GAD). ADAA, March 17-20 2005, Seattle, WA.
   Google Scholar
• Thase ME, Rush AJ. When at first you don't succeed: sequential strategies for antidepressant nonresponders. J Clin Psychiatry 1997; 58(Suppl 13)23–9
   PubMed Web of Science ®Google Scholar
• Fava M. Diagnosis and definition of treatment resistant depression. Biol Psychiatry. 2003; 53: 649–59
   PubMed Web of Science ®Google Scholar
• The European Agency for the Evaluation of Medicinal Products. Evaluation of Medicines for Human Use. London, 25 April 2002 CPMP/EWP/518/97, Rev.1.
   Google Scholar
• Ketter TA, Calabrese JR. Stabilization of mood from below versus above baseline in bipolar disorder: a new nomenclature. J Clin Psychiatry 2002; 63(2)146–51
   PubMed Web of Science ®Google Scholar
• Vieta, E, Goikolea, JM. Atypical antipsychotics: newer options for mania and maintenance therapy. Bipolar Disord 2005; 7(Suppl 4):21–33. :21–33.
   PubMed Web of Science ®Google Scholar
• Tohen M, Vieta E, Calabrese J, Ketter TA, Sachs G, Bowden C, et al. Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression. Arch Gen Psychiatry 2003; 60(11)1079–88
   PubMed Web of Science ®Google Scholar
• Calabrese JR, Keck PE, Jr, Macfadden W, Minkwitz M, Ketter TA, Weisler RH, et al. A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression. Am J Psychiatry 2005; 162(7)1351–60
   PubMed Web of Science ®Google Scholar
• Schlaepfer TE, Kosel M, Nemeroff CB. Efficacy of repetitive transcranial magnetic stimulation (rTMS) in the treatment of affective disorders. Neuropsychopharmacology 2003; 28: 201–5
   PubMed Web of Science ®Google Scholar
• Fitzgerald PB, Brown TL, Marston NA, Daskalakis ZJ, De Castella A, Kulkarni J. Transcranial magnetic stimulation in the treatment of depression: a double-blind, placebo-controlled trial. Arch Gen Psychiatry 2003; 60(10)1002–18
   PubMed Web of Science ®Google Scholar
• Lisanby SH, Luber B, Finck AD, Schroeder C, Sackeim HA. Deliberate seizure induction with repetitive transcranial magnetic stimulation in nonhuman primates. Arch Gen Psychiatry 2001; 58(2)199–200
   PubMed Web of Science ®Google Scholar
• Lisanby HS, Luber B, Schlaepfer TE, Sackeim HA. Safety and feasibility of magnetic seizure therapy (MST) in major depression: Randomized within-subject comparison with electroconvulsive therapy. Neuropsychopharmacology 2003; 28(7)1852–65
   PubMedGoogle Scholar
• Schlaepfer, TE. Progress in Therapeutic Brain Stimulation in Neuropsychiatry. In: TE Schlaepfer, ed. Brain Stimulation Methods in the Treatment of Affective Disorders, vol 8., New York, CNS Spectrums, 2003: 488.
   Google Scholar
• Kosel M, Schlaepfer TE. Beyond the treatment of epilepsy: New applications of vagus nerve stimulation (VNS) in psychiatry. CNS Spectrums 2003; 8(7)515–21
   PubMed Web of Science ®Google Scholar
• Mayberg HS, Lozano AM, Voon V, McNeely HE, Seminowicz D, Hamani C, Schwalb JM, Kennedy SH. Deep brain stimulation for treatment-resistant depression. Neuron 2005; 45: 651–60
   PubMed Web of Science ®Google Scholar
• Schlaepfer, TE, Lieb, K. Deep brain stimulation for treatment refractory depression. Lancet 2005; in press.
   PubMed Web of Science ®Google Scholar
• Roussou, A. (2002). Psychometric issues in clinical action and research. Athens: Hellenic letters.
   Google Scholar
• Herbert, M. (1990). Psychological problems of childhood (Vol 1&2). Athens: Hellenic letters.
   Google Scholar
• Pjrek E, Winkler D, Heiden A, et al. Seasonality of birth in seasonal affective disorder. J Clin Psychiatry 2004; 65: 1389–93
   PubMed Web of Science ®Google Scholar
• McNeil T, Kaij L, Dzierzykray-Rogalska M. Season of birth among siblings of schizophrenics: A test of the parental conception habits interpretation. Acta Psychiatr Scand 1976; 54: 267–74
   PubMed Web of Science ®Google Scholar
• McIntyre, RS, , et al. Eur Neuropsychopharmacol. 2005: in press.
   Google Scholar
• Bowden C, et al. J Clin Psychiatry 2005; 66: 111–21
   PubMed Web of Science ®Google Scholar
• Vieta E, et al. Curr Med Res Opin 2005; 21: 923–34
   PubMed Web of Science ®Google Scholar
• Rosenthal NE, Sack DA, Gillin JC, et al. Seasonal affective disorder. A description of the syndrome and preliminary findings with light therapy. Arch Gen Psychiatry 1984; 41: 72–80
   PubMed Web of Science ®Google Scholar
• Winkler D, Praschak-Rieder N, Willeit M, et al. Seasonal affective depression in two German speaking university centers: Bonn, Vienna. Clinical and demographic characteristics. Nervenarzt. 2002; 73: 637–43
   PubMed Web of Science ®Google Scholar